0001200876-22-000025.txt : 20220504
0001200876-22-000025.hdr.sgml : 20220504
20220504081738
ACCESSION NUMBER: 0001200876-22-000025
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20220504
DATE AS OF CHANGE: 20220504
EFFECTIVENESS DATE: 20220504
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xenetic Biosciences, Inc.
CENTRAL INDEX KEY: 0001534525
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 452952962
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-444330
FILM NUMBER: 22889905
BUSINESS ADDRESS:
STREET 1: 40 SPEEN STREET, SUITE 102
CITY: FRAMINGHAM
STATE: MA
ZIP: 01701
BUSINESS PHONE: 781-778-7720
MAIL ADDRESS:
STREET 1: 40 SPEEN STREET, SUITE 102
CITY: FRAMINGHAM
STATE: MA
ZIP: 01701
FORMER COMPANY:
FORMER CONFORMED NAME: General Sales & Leasing, Inc.
DATE OF NAME CHANGE: 20130227
FORMER COMPANY:
FORMER CONFORMED NAME: GENERAL AIRCRAFT INC.
DATE OF NAME CHANGE: 20111108
D
1
primary_doc.xml
X0708
D
LIVE
0001534525
Xenetic Biosciences, Inc.
40 SPEEN STREET, SUITE 102
FRAMINGHAM
MA
MASSACHUSETTS
01701
781-778-7720
NEVADA
General Sales & Leasing, Inc.
GENERAL AIRCRAFT INC.
Corporation
true
Jeffrey
Eisenberg
40 Speen Street, Suite 102
Framingham
MA
MASSACHUSETTS
01701
Executive Officer
Director
Chief Executive Officer
James
Parslow
40 Speen Street, Suite 102
Framingham
MA
MASSACHUSETTS
01701
Executive Officer
Chief Financial Officer
Adam
Logal
40 Speen Street, Suite 102
Framingham
MA
MASSACHUSETTS
01701
Director
Curtis
Lockshin
40 Speen Street, Suite 102
Framingham
MA
MASSACHUSETTS
01701
Executive Officer
Chief Science Officer
Grigory
Borisenko
40 Speen Street, Suite 102
Framingham
MA
MASSACHUSETTS
01701
Director
James
Callaway
40 Speen Street, Suite 102
Framingham
MA
MASSACHUSETTS
01701
Director
Firdaus
Dastoor
40 Speen Street, Suite 102
Framingham
MA
MASSACHUSETTS
01701
Director
Alexey
Vinogradov
40 Speen Street, Suite 102
Framingham
MA
MASSACHUSETTS
01701
Director
Roger
Kornberg
40 Speen Street, Suite 102
Framingham
MA
MASSACHUSETTS
01701
Director
Biotechnology
$1,000,001 - $5,000,000
- 06b
false
2022-04-26
false
true
true
Up to 950,000 Common Shares (equity) may be issued in the future if certain regulatory milestones are achieved under various license agreements, which may not occur.
false
0
866250
866250
0
Up to 950,000 Common Shares (equity) may be issued in the future if certain regulatory milestones are achieved under various license agreements, which may not occur. Such amount cannot be calculated at this time.
false
2
0
0
0
false
Xenetic Biosciences, Inc.
/s/James Parslow
James Parslow
CFO
2022-05-03